We're going to do this in people that have cognitive deficits, and we've chosen to treat patients with Alzheimer's disease who have cognitive and memory deficits.
Kjo do te kryhet ne njerez qe kane mangesi njohese, dhe kemi vendosur te zgjedhim paciente qe vuajne nga Alzhaimer te cilet kane humbur memorjen.